NASDAQ:LHCGLHC Group Stock Price, Forecast & News

LHC Group's stock was trading at $127.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, LHCG stock has increased by 25.9% and is now trading at $159.94. View which stocks have been most impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for LHC Group.

LHC Group is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for LHC Group.

LHC Group, Inc. (NASDAQ:LHCG) released its quarterly earnings results on Thursday, May, 7th. The health services provider reported $0.75 earnings per share for the quarter, beating analysts' consensus estimates of $0.69 by $0.06. The health services provider earned $512.90 million during the quarter, compared to analysts' expectations of $504.41 million. LHC Group had a net margin of 4.73% and a return on equity of 8.89%. The business's revenue for the quarter was up 2.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.98 EPS. View LHC Group's earnings history.

10 brokerages have issued twelve-month price objectives for LHC Group's shares. Their forecasts range from $120.00 to $200.00. On average, they expect LHC Group's share price to reach $157.89 in the next twelve months. This suggests that the stock has a possible downside of 1.3%. View analysts' price targets for LHC Group.

Media headlines about LHCG stock have trended somewhat positive on Friday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. LHC Group earned a media sentiment score of 0.7 on InfoTrie's scale. They also gave press coverage about the health services provider a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an effect on the company's share price in the near future. View the latest news aboutLHC Group.

LHC Group saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 1,240,000 shares, a decline of 12.7% from the April 30th total of 1,420,000 shares. Based on an average trading volume of 461,500 shares, the days-to-cover ratio is presently 2.7 days. Currently, 4.1% of the company's stock are sold short. View LHC Group's Current Options Chain.

Some companies that are related to LHC Group include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), AMN Healthcare Services (AMN), MEDNAX (MD), CorVel (CRVL), R1 RCM (RCM), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), Home Depot (HD), Alibaba Group (BABA), Cisco Systems (CSCO), CVS Health (CVS), Chevron (CVX), Honeywell International (HON), Intel (INTC), Visa (V) and Walt Disney (DIS).

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (16.98%), Invesco Ltd. (5.61%), Wellington Management Group LLP (3.49%), State Street Corp (2.95%), Victory Capital Management Inc. (2.09%) and Victory Capital Management Inc. (2.09%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View institutional ownership trends for LHC Group.

LHCG stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Alliancebernstein L.P., GW&K Investment Management LLC, Magnetar Financial LLC, Morgan Stanley, Morgan Stanley, Summit Creek Advisors LLC, and Rothschild & Co. Asset Management US Inc.. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, and John L Indest. View insider buying and selling activity for LHC Group.

LHCG stock was acquired by a variety of institutional investors in the last quarter, including Invesco Ltd., Eagle Asset Management Inc., Eaton Vance Management, BlackRock Inc., TimesSquare Capital Management LLC, Thrivent Financial for Lutherans, Wellington Management Group LLP, and Ziegler Capital Management LLC. View insider buying and selling activity for LHC Group.

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of LHCG stock can currently be purchased for approximately $159.94.

LHC Group has a market capitalization of $5.05 billion and generates $2.08 billion in revenue each year. The health services provider earns $95.73 million in net income (profit) each year or $4.47 on an earnings per share basis. LHC Group employs 30,399 workers across the globe.

The official website for LHC Group is www.lhcgroup.com.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]